boardroom 1.jpg

About Us

Taking Back Health

Promethean BioPharma is the global benchmark in diversified cannabis consumer and medical products and the commercialisation of novel medicines such as psilocybin and MDMA. We are a company driven by a desire to harness the full potential of these once prohibited medicines and substances within legal frameworks as they mature globally.

At Promethean BioPharma, we work closely with health professionals to drive the science forward and work towards improving patient outcomes, health and wellness for everyone.

Our strategy is built with a focus on range, reach and access across our manufacturing, supply chain and intellectual property. This ensures that Promethean BioPharma is positioned to supply into all legal markets currently and when they emerge. We are one company partnered across all emerging novel medicine products and across all market channels including medical, health and wellbeing, and recreation.

What we do

Sales, advocacy, product and contract manufacturing, global partnerships, business development and distribution. We listen, learn, partner and develop an understanding on future trends.

What we make

Novel medicines including cannabis products, oils and tinctures, creams and ointments, sprays and dried flower, ingredients and processing, and contract services.

Who we serve

Doctors, pharmacists, patients, consumers, client companies and brands in Australia and with partnerships for Europe, North America, Middle-East and Asia.

We invite you to join us as a Promethean.
Be a partner, an investor, a client or just be the spirit of Prometheus.
Come and be a Promethean with us and together, we will change the world for the better.

Our extensive capabilities make us a global market leader

Global executive and leadership team of doctors, business professionals, pharmaceutical and hospital executives, manufacturing and quality leaders, international thought leaders and investors.

Global distribution partnerships and direct access to patient, practitioner and consumer markets.

Branded and white label cannabis products.

 

Global partnerships in psilocybin and MDMA.

 

Extraction and manufacturing technology and expertise in manufacturing.

 

Support tools for agricultural best practice.

Australian, Canadian and USA cultivation, Research and Manufacturing licenses.

 

Research and development expertise (pharmaceutical and clinical trials).

 

Good Manufacturing Practice (GMP) accredited facilities and partners in Australia, Canada, America, Europe, Asia.

 

Cost leadership and price advantage.